{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:35:49Z","timestamp":1785278149446,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T00:00:00Z","timestamp":1348531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00423-012-1005-x","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T04:32:36Z","timestamp":1348461156000},"page":"131-138","source":"Crossref","is-referenced-by-count":7,"title":["Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism"],"prefix":"10.1007","volume":"398","author":[{"given":"Denis","family":"Wirowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Goretzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard J.","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,25]]},"reference":[{"key":"1005_CR1","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1517\/17425250802587017","volume":"4","author":"P Messa","year":"2008","unstructured":"Messa P, Alfieri C, Brezzi B (2008) Cinacalcet: pharmacological and clinical aspects. Expert Opin Drug Metab Toxicol 4:1551\u20131560. doi: 10.1517\/17425250802587017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1005_CR2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco ALM, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Dr\u00fceke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516\u20131525","journal-title":"N Engl J Med"},{"key":"1005_CR3","doi-asserted-by":"crossref","first-page":"c109","DOI":"10.1159\/000319882","volume":"118","author":"J Bover","year":"2010","unstructured":"Bover J, P\u00e9rez R, Molina M, Benavides B, Ariza F, Miguel JL, Tornero F, Torregrosa JV (2010) Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients: an observational study in routine clinical practice. Nephron Clin Pract 118:c109\u2013c121. doi: 10.1159\/000319882","journal-title":"Nephron Clin Pract"},{"key":"1005_CR4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/14656566.9.5.795","volume":"9","author":"ALM Francisco de","year":"2008","unstructured":"de Francisco ALM (2008) New strategies for the treatment of hyperparathyroidism incorporating calcimimetics. Expert Opin Pharmacother 9:795\u2013811. doi: 10.1517\/14656566.9.5.795","journal-title":"Expert Opin Pharmacother"},{"key":"1005_CR5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00104-010-1968-5","volume":"81","author":"C Dotzenrath","year":"2010","unstructured":"Dotzenrath C (2010) Indications for parathyroidectomy in renal hyperparathyroidism. Comments on the significance of new therapeutics. Chirurg 81:902\u2013908. doi: 10.1007\/s00104-010-1968-5","journal-title":"Chirurg"},{"key":"1005_CR6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","volume":"44","author":"A Lishmanov","year":"2012","unstructured":"Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A (2012) Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 44:541\u2013547. doi: 10.1007\/s11255-010-9897-2","journal-title":"Int Urol Nephrol"},{"key":"1005_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00774-009-0048-8","volume":"27","author":"DH Smith","year":"2009","unstructured":"Smith DH, Johnson ES, Thorp ML, Yang X, Neil N (2009) Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcome. J Bone Miner Metab 27:287\u2013294. doi: 10.1007\/s00774-009-0048-8","journal-title":"J Bone Miner Metab"},{"key":"1005_CR8","first-page":"CD006254","volume":"18","author":"GFM Strippoli","year":"2006","unstructured":"Strippoli GFM, Tong A, Palmer SC, Elder GJ, Craig JC (2006) Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev 18:CD006254. doi: 10.1002\/14651858.CD006254","journal-title":"Cochrane Database Syst Rev"},{"key":"1005_CR9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.surg.2007.06.015","volume":"142","author":"V Costa-Hong","year":"2007","unstructured":"Costa-Hong V, Jorgetti V, Gowdak LHW, Moyses RMA, Krieger EM, De Lima JJG (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 142:699\u2013703. doi: 10.1016\/j.surg.2007.06.015","journal-title":"Surgery"},{"key":"1005_CR10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1440-1797.2005.00476.x","volume":"10","author":"GJ Elder","year":"2005","unstructured":"Elder GJ (2005) Parathyroidectomy in the calcimimetic era. Nephrology (Carlton) 10:511\u2013515. doi: 10.1111\/j.1440-1797.2005.00476.x","journal-title":"Nephrology (Carlton)"},{"key":"1005_CR11","doi-asserted-by":"crossref","unstructured":"Lorenz K, Sekulla C, Dralle H (2011) Surgical management of renal hyperparathyroidism. Zentralbl Chir. doi: 10.1055\/s-0030-1262542","DOI":"10.1055\/s-0030-1262542"},{"key":"1005_CR12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00268-007-9318-6","volume":"32","author":"K Schlosser","year":"2008","unstructured":"Schlosser K, Schmitt CP, Bartholomaeus JE, Suchan KL, Buchler MW, Rothmund M, Weber T (2008) Parathyroidectomy for renal hyperparathyroidism in children and adolescents. World J Surg 32:801\u2013806. doi: 10.1007\/s00268-007-9318-6","journal-title":"World J Surg"},{"key":"1005_CR13","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int 113:S1\u2013S130. doi: 10.1038\/ki.2009.188(-197)","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"1005_CR14","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S1\u2013S201. doi: 10.1016\/S0272-6386(03)00905-3","journal-title":"Am J Kidney Dis"},{"key":"1005_CR15","unstructured":"Amgen Inc. (2004\u20132011) Sensipar\u00ae (cinacalcet) tablets. Full prescribing information. Available at http:\/\/pi.amgen.com\/united_states\/sensipar\/sensipar_pi_hcp_english.pdf . Accessed 31 Oct 2011"},{"key":"1005_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0030-1247876","volume":"136","author":"H Reichel","year":"2011","unstructured":"Reichel H, Braun J (2011) German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY). Dtsch Med Wochenschr 136:123\u2013128. doi: 10.1055\/s-0030-1247876","journal-title":"Dtsch Med Wochenschr"},{"key":"1005_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1517\/17425255.2011.562196","volume":"7","author":"P Messa","year":"2011","unstructured":"Messa P, Alfieri C, Brezzi B (2011) Clinical utilization of cinacalcet in hypercalcemic conditions. Expert Opin Drug Metab Toxicol 7:517\u2013528. doi: 10.1517\/17425255.2011.562196","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1005_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5414\/CN106965","volume":"76","author":"JM Fraz\u00e3o","year":"2011","unstructured":"Fraz\u00e3o JM, Messa P, Mellotte GJ, Geiger H, Hagen EC, Quarles LD, Kerr PG, Ba\u00f1os A, Dehmel B, Urena P (2011) Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity. Clin Nephrol 76:233\u2013243. doi: 10.5414\/CN106965","journal-title":"Clin Nephrol"},{"key":"1005_CR19","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfp144","volume":"24","author":"P Ure\u00f1a","year":"2009","unstructured":"Ure\u00f1a P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Sha H, Ryba M, Bencova V, Ba\u00f1os A, Zani V, Fouque D (2009) Cinacalcet and achievement of the NKF\/K-DOQI\u2122 recommended target values for bone and mineral metabolism in real-world clinical practice\u2014the ECHO observational study. Nephrol Dial Transplant 24:2852\u20132859. doi: 10.1093\/ndt\/gfp144","journal-title":"Nephrol Dial Transplant"},{"key":"1005_CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MJT.0b013e3181bdc3d0","volume":"18","author":"ML Dillon","year":"2011","unstructured":"Dillon ML, Frazee LA (2011) Cinacalcet for the treatment of primary hyperparathyroidism. Am J Ther 18:313\u2013322. doi: 10.1097\/MJT.0b013e3181bdc3d0","journal-title":"Am J Ther"},{"key":"1005_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12020-011-9452-7","volume":"39","author":"LH Duntas","year":"2011","unstructured":"Duntas LH, Stathatos N (2011) Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects. Endocrine 39:199\u2013204. doi: 10.1007\/s12020-011-9452-7","journal-title":"Endocrine"},{"key":"1005_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jc.2008-1762","volume":"94","author":"A Khan","year":"2009","unstructured":"Khan A, Grey A, Shoback D (2009) Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:373\u2013381. doi: 10.1210\/jc.2008-1762","journal-title":"J Clin Endocrinol Metab"},{"key":"1005_CR23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.metabol.2007.11.014","volume":"57","author":"S Sajid-Crockett","year":"2008","unstructured":"Sajid-Crockett S, Singer FR, Hershman JM (2008) Cinacalcet for the treatment of primary hyperparathyroidism. Metabolism 57:517\u2013521. doi: 10.1016\/j.metabol.2007.11.014","journal-title":"Metabolism"},{"key":"1005_CR24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2362.2007.01874.x","volume":"37","author":"RP W\u00fcthrich","year":"2007","unstructured":"W\u00fcthrich RP, Martin D, Bilezikian JP (2007) The role of calcimimetics in the treatment of hyperparathyroidism. Eur J Clin Invest 37:915\u2013922. doi: 10.1111\/j.1365-2362.2007.01874.x","journal-title":"Eur J Clin Invest"},{"key":"1005_CR25","doi-asserted-by":"crossref","unstructured":"Moyes VJ, Monson JP, Chew SL, Akker SA (2010) Clinical use of cinacalcet in MEN1 hyperparathyroidism. Int J Endocrinol. doi: 10.1155\/2010\/906163","DOI":"10.1155\/2010\/906163"},{"key":"1005_CR26","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM (2005) Effects of the calcimimetic cinacalcet HCL on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68:1793\u20131800. doi: 10.1111\/j.1523-1755.2005.00596.x","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"1005_CR27","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1744-9987.2009.00770.x","volume":"13","author":"M Taniguchi","year":"2009","unstructured":"Taniguchi M, Yamada S, Tokumoto M, Tsuruya K, Hirakata H, Fujimi S, Iida M (2009) Does cinacalcet improve the prognosis of dialysis patients? Ther Apher Dial 13(Suppl 1):S15\u2013S19. doi: 10.1111\/j.1744-9987.2009.00770.x","journal-title":"Ther Apher Dial"},{"key":"1005_CR28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/145749690409300407","volume":"93","author":"K Schlosser","year":"2004","unstructured":"Schlosser K, Zielke A, Rothmund M (2004) Medical and surgical treatment for secondary and tertiary hyperparathyroidism. Scand J Surg 93:288\u2013297","journal-title":"Scand J Surg"},{"key":"1005_CR29","unstructured":"Schneider R, Bartsch DK, Schlosser K (2011) Hat sich das preoperative Erscheinungsbild vor Parathyreoidektomien bei Patienten mit sekund\u00e4rem Hyperparathyreoidismus im Zeitverlauf und durch neue medikament\u00f6se Therapieoptionen ver\u00e4ndert? Abstract, 128th Congress of the German Society of Surgery 2011, Munich, Germany"},{"key":"1005_CR30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/000313480907500918","volume":"75","author":"MO Meyers","year":"2009","unstructured":"Meyers MO, Russell CP, Ollila DW, Yeh JJ, Kim HJ, Calvo BF (2009) Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of cinacalcet. Am Surg 75:843\u2013847","journal-title":"Am Surg"},{"key":"1005_CR31","doi-asserted-by":"crossref","unstructured":"Ghani A, Baxter P (2011) Surgical parathyroidectomy versus cinacalcet therapy: in the management of secondary hyperparathyroidism. Otolaryngol Head Neck Surg. doi: 10.1177\/0194599811428272","DOI":"10.1177\/0194599811428272"},{"key":"1005_CR32","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","volume":"20","author":"SM Moe","year":"2005","unstructured":"Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM (2005) Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20:2186\u20132193. doi: 10.1093\/ndt\/gfh966","journal-title":"Nephrol Dial Transplant"},{"key":"1005_CR33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1744-9987.2010.00843.x","volume":"14","author":"T Hirai","year":"2010","unstructured":"Hirai T, Nakashima A, Takasugi N, Yorioka N (2010) Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients. Ther Apher Dial 14:577\u2013582. doi: 10.1111\/j.1744-9987.2010.00843.x","journal-title":"Ther Apher Dial"},{"key":"1005_CR34","doi-asserted-by":"crossref","first-page":"c187","DOI":"10.1159\/000262301","volume":"114","author":"T Hirai","year":"2010","unstructured":"Hirai T, Nakashima A, Takasugi N, Yorioka N (2010) Response of secondary hyperparathyroidism to cinacalcet depends on parathyroid size. Nephron Clin Pract 114:c187\u2013c193. doi: 10.1159\/000262301","journal-title":"Nephron Clin Pract"},{"issue":"Suppl 1","key":"1005_CR35","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1744-9987.2008.00627.x","volume":"12","author":"Y Tominaga","year":"2008","unstructured":"Tominaga Y, Matsuoka S, Uno N, Sato T (2008) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12(Suppl 1):S21\u2013S26. doi: 10.1111\/j.1744-9987.2008.00627.x","journal-title":"Ther Apher Dial"},{"key":"1005_CR36","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/ndt\/gfr589","volume":"27","author":"G Miller","year":"2012","unstructured":"Miller G, Davis J, Shatzen E, Colloton M, Martin D, Henley CM (2012) Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD. Nephrol Dial Transplant 27:2198\u20132205. doi: 10.1093\/ndt\/gfr589","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1005_CR37","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1744-9987.2009.00772.x","volume":"13","author":"T Kakuta","year":"2009","unstructured":"Kakuta T, Tanaka R, Kanai G, Sawaya A, Hirukawa T, Sato A, Saito A (2009) Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism? Ther Apher Dial 13(1):S20\u2013S27. doi: 10.1111\/j.1744-9987.2009.00772.x","journal-title":"Ther Apher Dial"},{"key":"1005_CR38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","volume":"49","author":"R Narayan","year":"2007","unstructured":"Narayan R, Perkins RM, Berbano EP, Yuan CM, Neff RT, Sawyers ES, Yeo FE, Vidal-Trecan GM, Abbott KC (2007) Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 49:801\u2013813. doi: 10.1053\/j.ajkd.2007.03.009","journal-title":"Am J. Kidney Dis"},{"key":"1005_CR39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.surg.2010.09.009","volume":"148","author":"R Schneider","year":"2010","unstructured":"Schneider R, Kolios G, Koch BM, Fern\u00e1ndez ED, Bartsch DK, Schlosser K (2010) An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism\u2014the German perspective. Surgery 148:1091\u20131099. doi: 10.1016\/j.surg.2010.09.009","journal-title":"Surgery"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-012-1005-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-012-1005-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-012-1005-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T14:19:36Z","timestamp":1643465976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-012-1005-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1007\/s00423-012-1005-x","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,25]]}}}